Neuroendocrine tumors (NETs) are a heterogeneous group of tumors originating in various locations, including the gastrointestinal tract, lung, and pancreas. The disease management poses a significant challenge because of the heterogeneous clinical presentations and varying degrees of aggressiveness. The recent completion of several phase III trials, including those evaluating octreotide, sunitinib, and everolimus, demonstrate that rigorous evaluation of novel agents in this disease is possible and can lead to practice-changing outcomes. Nevertheless, there are many aspects to the treatment of NETs that remain unclear and controversial.

The North American Neuroendocrine Tumor Society (NANETS) was founded in 2006 and at that time its board members convened a Consensus Guidelines Committee in an effort to develop an expert consensus opinion on the treatment of these uncommon diseases. Though other comprehensive guidelines exist (i.e. NCCN Neuroendocrine Tumor Guidelines, European Neuroendocrine Tumor Society (ENETs) Guidelines), it was felt that the NANETS guidelines could enhance and complement these existing guidelines through the use of expert opinion added to evidenced-based recommendations.   For more information on the management of NETS, go to Consensus Guidelines for the Management and Treatment.

General Information

NANETS is committed to furthering neuroendocrine tumor disease diagnosis, treatment and management through research and education. NANETS encourages abstract reporting on recent NET research and/or describing ongoing or current clinical trials with the intent of increasing awareness of these studies. Investigators may submit abstracts that have been presented at other scientific meetings and/or published in scientific journals since October 1, 2025. For reference in writing a successful abstract, please visit the NANETS Abstracts Library for examples.

Please read ALL instructions carefully before submitting your Abstract. The Abstract Submission Portal is located at the end of this page.

Requirements and Expectations

All presenters whose abstracts are accepted are required to a) join NANETS and b) register for the Symposium. Please note that registration fees are discounted for NANETS members in good standing. Membership information can be found HERE. Accepted abstract presenters are expected to prepare and present a poster of the accepted abstract during the poster session at the Symposium.

Travel

The Symposium is November 5-7, 2026 in Las Vegas, NV, USA. By submitting an abstract, you are committing to attending the Symposium, if accepted. Please check your passport and other required travel documentation well in advance.

Travel Grants

At least 10 travel grants will be awarded to members of NANETS who have submitted a highly scored abstract. The grants provide complimentary registration and up to $1,000 reimbursement toward airfare and/or hotel accommodations.

Some grants will be offered in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. They recognize the need for more early career professionals to enter NET research or clinical practice, with consideration for equity and inclusion of all groups in keeping with our diversity statement. Candidates should have a well-established interdisciplinary mentoring program to help further their career.

You will have the opportunity to apply for a grant during the abstract submission process. The following professionals may be considered for a travel grant:

Graduate Students (must have a letter of support from the program director)
Fellows
Allied Healthcare Professionals
Post-Doctoral Fellows
Residents (must have a letter of support from the program director)
Junior Faculty (within 5 years of fellowship training or postgraduate appointment)
First or Last Author on the abstract and poster who meet eligibility criteria

In the past, those chosen for oral presentations were automatically covered for registration and travel expenses like a speaker. That will NOT be the case this year. All eligible professionals should be sure to enter their interest in a travel grant as part of the submission process.

Communication

Communication will go through the online abstract processing system. The submitter should be the presenting author or if you are submitting on behalf of the presenting author, you will need to add their contact information and list them as a presenter. It is the responsibility of the submitter to stay abreast of and relay vital communication to the team of authors.
Questions can be addressed to This email address is being protected from spambots. You need JavaScript enabled to view it..

Important dates to remember:

3/14/2026: Open call for abstracts
7/3/2026: Close abstract submissions 
On or about 9/4/2026: Abstract notifications sent
9/11/2026: Last day for authors to confirm their oral/poster presentations

Submission Information

Portal Profile: If you are the presenting author or are submitting on behalf of the presenting author, please create a portal account under the name of the presenting author. If you are a sub author, submitting on behalf of the presenting author, be prepared to submit your own CV and the CV of the main presenter.

PLEASE NOTE: Even if you have used the submission portal for previous NANETS activities, additional information may be collected in the profile data. You will need to review and update your profile information, or it will appear incomplete. Specifically, the “Institution type” and “Race” questions may need completion again for some users.

All submissions will be required to upload a resume, CV, or brief bio and complete a Continuing Education Agreement. Edits can be made to your portal profile at any time.

Title and Track

Title: The title should clearly identify the contents of the abstract. Please do not identify the company or institution name in the title. Enter the title exactly as you would like it to appear. Titles are case-sensitive and must be twenty (20) or fewer words in length.

Track: Select the primary track for your abstract. Reviewers may modify the track after submission.

Affirmations

Review the following statements before submitting your abstract:

I certify that this study has been approved by any applicable oversight/ethics committee (e.g., IRB, EC, IACUC, etc.)
I understand that NANETS has the right to publish all accepted abstracts.
I understand that the submission of an abstract does not guarantee acceptance for presentation at the Annual Symposium.
I understand that if accepted, I am responsible for registering for the Symposium and arranging for travel to Las Vegas, Nevada, USA. (At least 10 travel grants may be awarded. Please be sure to complete the questions on the Questionnaire page if you are interested in applying for a travel grant).
I understand that, if accepted, I must be a member of NANETS in good standing at the time of presentation.

Abstract Content

The word limit for all four sections combined is 400 words. The word count does not include title, author names or institutions. One data table no larger than 10 rows × 5 columns is permitted per abstract and is counted in the word count.

Abstracts must include the following four sections in order to be submitted for review:

Background: The problem under investigation or a hypothesis.
Methods: The experimental methods or protocols used to accomplish the research.
Results: The key points derived from experiments.
Conclusion: A summary of your findings that are supported by the data presented.

You can cut and paste text or type directly in the section boxes.

Authors and Affiliations

Please include all non-presenting authors. Each author is entered on a separate line. First names should be complete and not just given as an initial. Each author may have up to two affiliations. Please make sure that if multiple authors share the same affiliation that the affiliation is entered exactly the same for each author.

First Author: Should be listed first. The author order in the abstract book will be based on the order you select.

Presenting Author: Please indicate which author will be the presenting author. If the presenting author is not registered to attend the conference, the abstract will be removed from the abstract book and Symposium program.

Corresponding Author: All emails regarding the submission will be sent to the submitter.

You are required to obtain the approval of all co-authors before placing their names on the abstract. Failure to do so will result in the immediate rejection of the abstract.

If submitting an abstract on behalf of someone else, you must add the presenting author’s name and contact information.

For first, presenting, and senior authors, we will also ask if they are early career. This designation is important for the consideration of travel grants and awards. Early career is defined as: Graduate Students, Fellows, Allied Healthcare Professionals, Post-Doctoral Fellows, Residents, Junior Faculty (within 5 years of fellowship training or postgraduate appointment).

Tables

Tables must include a title, are restricted to conclusive findings and are limited to 10 single rows and 4 columns.

Tables must be less than one-quarter the size of the complete abstract.

Tables may not substitute for the required sections.

Tables are included in the word count.

Merged cells, shading and other formatting are not permitted.

Reviewers reserve the right to request modified tables prior to publication.

Figures and illustrations are not permitted.

Table Header - This is the overall title of the table and will be centered across all columns
Table Footer - This is the footer of the table and will be centered at the bottom of the table.
Do not include references. Any references included will be removed.

Questionnaire

1. Is the presenter a NANETS member? Select Yes/No/Not at present but will join prior to Symposium

2. Has the primary author previously presented this abstract? If yes, enter details such as name, location and date.

3. Do you want to receive anonymous reviewer comments? Anonymous reviewer comments may be available upon request.

Travel Grant

Please refer to the travel grant specifications above.

Select the type of travel grant, if any, you would like to be considered for.

Enter the name of the travel grantee.

Select the category of the traveler.

Note that graduate students and residents are required to submit a letter of support from their program director. Accepted file types: PDF, Word Document, Apple Pages Document

Submitter Role

If you are not the presenting author, you must select “will not” in the submitter role section.

The presenting author’s Name and Email can be added on the next page.

NOTE: The contact information, CV/Resume/Brief Bio, CE Agreement, and Conflict of Interest must be completed for the submitter AND the presenting author. If all of these items are not complete, the system will not allow Abstract submission.

Abstract Submission Process

Abstracts must be submitted via our online system by the deadline of July 3, 2026 (11:59 pm EDT) per the instructions on the submission form. Photocopies or facsimile copies will not be accepted and will be discarded.

If no author listed on the abstract can present the poster at the symposium, the abstract must be withdrawn by September 11, 2026.

The presenting author must register and pay for the NANETS symposium no later than September 11, 2026, or the abstract will be pulled from the abstract book, and poster session, and will not be published.

You will be sent an email confirmation that your submission was received.

Possible outcomes of your submission:

1) Your abstract is accepted and you are asked to give an oral presentation on the topic as well as a poster presentation;

2) Your abstract is accepted and you are asked to provide a poster presentation;

3) Your abstract is rejected.

Questions can be directed to This email address is being protected from spambots. You need JavaScript enabled to view it..

Access the Abstract Submission Portal here.

 


Background

The North American Neuroendocrine Tumor Society (NANETS) was established in 2007 with the mission of furthering neuroendocrine tumor disease diagnosis, treatment and management. Since its inception, NANETS has remained dedicated to this mission through the provision of increased education and research opportunities. NANETS is committed to connecting pioneers in the NET field to the young scientific minds who will make up the next generation of NET experts. It is through research that NANETS engages medical professionals in the early part of their careers to foster further exploration and advancement of NET diagnosis and treatment.

Since 2009, NANETS has awarded $3 million in research grants to 37 medical professionals who have dedicated themselves to pursue a career in the field of neuroendocrinology and NET disease. Please visit our Grant Recipients Page to see the range of research supported through NANETS over the years or download our Grants Compendium below.

2025 Grants Compendium

This year, NANETS is offering two research grants to support innovative research initiatives and encourage young researchers and scientific clinicians to become NET specialists. Please click on the links to read the specifications for each grant.

1. NANETS Basic/Translational Science Investigator Grant (BTSI), supported by the Neuroendocrine Tumor Research Foundation, $100,000 over two years beginning January 2026.

2. NANETS Clinical Investigator Scholarship (NCIS), supported by Novartis Pharmaceuticals Corporation, $50,000 over two years beginning January 2026 for stipends only.

These research opportunities are also made possible by the generous donations of NANETS members, patients and the families of those living with NETs.

Eligibility

NANETS welcomes applications from candidates who meet the following criteria:

Candidates must have a MD, PhD, MD/PhD, DO degree, or equivalent.

  • At the time of funding, candidates must be:
    Within 6 years of starting their first faculty position and currently have an academic appointment at an accredited medical school or other institution in North America,
  • OR hold a postdoctoral fellowship appointment at an accredited medical school or other institution in North America.
  • Candidates must be a NANETS member in good standing. 
  • Previous recipients of BTSI, NCIS, or NTIG awards are not eligible to apply.

 

 Application Review and Notification Process

 Applications are reviewed and scored by the NANETS’ Scientific Review & Research Committee comprised of NET medical research experts. Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor biology, epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance.

 

 Important Dates to Remember:

  • 6/26/2026, 11:59 pm Pacific Time: Deadline to submit
  • On or about 8/10/2026: Notifications sent
  • 8/18/2026: Last day to confirm acceptance of research grant
  • 9/30/2026: Letter of Agreement and all required paperwork due

 

 Submission Process

 Applications must be submitted via our online system by the deadline. Photocopies or facsimile copies will not be accepted and will be discarded.

● Login: If you are new to our portal, you will be asked to create a new account to submit yourapplication. NOTE: Upon account creation, you will be required to complete a profile page, fill out a conflict of interest form and upload a resume or CV.
● Please note: Even if you have used the submission portal for previous NANETS activities, additional information may be collected in the profile data. You will need to review and update your profile information, or it will appear incomplete. Specifically, the “Institution type” and “Race” questions may need to be completed again for some users.
● Editing a Proposal: You CAN NOT edit your proposal once it has been submitted.
● All communication will go through this system. You will be sent an email confirmation that your submission was received.

Submission Deadline: June 26, 2026 (23:59 PST)

PRINT INSTRUCTIONS

SUBMIT RESEARCH GRANT APPLICATION

General Information

The North American Neuroendocrine Tumor Society (NANETS) was established in 2007 with the mission of furthering neuroendocrine tumor disease diagnosis, treatment and management. Since its inception, NANETS has remained dedicated to this mission through the provision of increased education and research opportunities. NANETS is committed to connecting pioneers in the NET field to the young scientific minds who will make up the next generation of NET experts. It is through research that NANETS engages medical professionals in the early part of their careers to foster further exploration and advancement of NET diagnosis and treatment.

Since 2009, NANETS has awarded $2.8 million in research grants to 35 medical professionals who have dedicated themselves to pursue a career in the field of neuroendocrinology and NET disease. NANETS’ Research Grant Program supports innovative research initiatives and encourage young researchers and scientific clinicians to become NET specialists in the following areas:

  1. Basic/Translational Science
  2. Clinical Investigation
  3. Theranostics

These research opportunities are made possible by industry support and the generous donations of NANETS members, patients, and the families of those living with NETs.

Disclaimer: Funding is subject to the approval and availability of grant funds appropriated to NANETS. Therefore, NANETS reserves the right to alter the number of investigator awards, terms, and allowances.

This page contains important information. Please read before submitting.

  1. Eligibility
  2. Important Dates
  3. Submission, Review and Notification Process
  4. Step by Step Instructions for Online Submission 

Eligibility

NANETS welcomes applications from candidates who meet the following criteria:

  • Candidates must have a MD, PhD, MD/PhD, DO degree or equivalent.
  • At the time of funding, candidates must be:
    • Within 6 years of starting their first faculty position and currently have an academic appointment at an accredited medical school or other institution in North America,
    • OR hold a postdoctoral fellowship appointment at an accredited medical school or other institution in North America.
  • Candidates must be a NANETS member in good standing.
  • Previous recipients of NANETS’ research grants are not eligible to apply.

Important Dates:

  • Around 3/14/2026: Submission Period Begins
  • 6/26/2026 (11:59 pm PT): Deadline to submit
  • On or about 8/10/2026: Notifications sent
  • 8/18/2026: Last day to confirm acceptance of research grant
  • 9/30/2026: Letter of Agreement and all required paperwork due

Submission Process

  • Applications must be submitted via our online system by the deadline. Photocopies or facsimile copies will not be accepted and will be discarded.
  • Login: You will be asked to create a new account to submit your application
    NOTE: Upon account creation, you will be required to complete a profile page, fill out a conflict of interest form and upload a resume or CV.
  • Editing a Proposal: You CAN NOT edit your proposal once it has been submitted.
  • All communication will go through this system. You will be sent an email confirmation that your submission was received.

Application Review and Notification Process

Applications are reviewed and scored by the NANETS’ Scientific Review & Research Committee comprised of NET medical research experts. Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor biology, epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance. 

Access the grant submissions portal here.

Back to Top


Online Submission Information - Step by Step 

 

APPLICATION SECTIONS

The total word count is 2,750 words. Word counts are suggested for each section.
The online system will lead you through the following required sections. 

CONFLICT OF INTEREST DISCLOSURE

You will be required to complete a Conflict of Interest form before your Research Grant Submission can be completed.

TITLE AND CATEGORY

Project Title - Enter the title of your submission exactly how you would like it to appear. 20 words or less

Select Category of Grant:

    • NANETS Basic/Translational Science Investigator (BTSI)
    • NANETS Clinical Investigator Scholarship (NCIS)

ELIGIBILITY

Select Yes or No to confirm your eligibility to apply for a NANETS research grant (see eligibility above).

CAREER DEVELOPMENT PLAN

750 word limit. This should be written together by the mentor and applicant. It should include intramural coursework/seminars, involvement in cooperative groups, participation in tumor boards, description of clinical protected time and plans to attend national meetings focused on neuroendocrine tumors.

PERSONAL STATEMENT BY THE CANDIDATE

500 word limit. The applicant should include a description of any past projects, evidence of interest in neuroendocrine tumors, and description of how the project will contribute to the future development of the candidate as a basic science researcher and/or clinician in the field of neuroendocrine tumors.

MENTOR DEVELOPMENT PLAN

500 word limit. The mentor should include a description of how they will enhance the applicant’s career opportunities and leadership skills, outline their role in the mentoring relationship and ability to supervise the applicant, explain how they will provide a positive learning environment to include the institutional commitment of support for the mentor’s time. 

PROJECT DESCRIPTION

1,000 word limit. Please refer to the Selection Criteria outlined in the RFA and be sure to address the criteria specific to the grant for which you are applying. The rich text editor supports the creation or import of tables from Word, or you may upload a one page file in the next section for relevant figures or tables associated with the project. Permitted file type: PDF Document, Word Document 

PROPOSED BUDGET

Grant funds can be used to support the salary of the applicant, project costs and/or travel. Indirect expenses are capped at five percent (5%). Upload a detailed budget spreadsheet in this section.
Permitted file type: Excel Spreadsheet

NOTE to NTIG applicants: Grant funds are to be used to support the costs associated with the approved research project. Novartis funds cannot be used for overhead costs (such as indirect costs), travel expenses, meals or beverages, or transfers of value payments for: Physician Assistants; Nurse Practitioners; Clinical Nurse Specialists; Certified Nurse Midwives; Certified Registered Nurse Anesthetists; and Anesthesiologist Assistants.

REQUIRED UPLOADS

Permitted file types: PDF Document, Word Document, Apple Pages Document

    1. NIH Biosketch of Applicant (5 page maximum)
    2. NIH Biosketch of Mentor (5 page maximum)
    3. Letter of Mentor Support (1 page maximum)
    4. Letter of Institutional Support (1 page maximum)
    5. Optional: Figures and tables (1 page maximum)

OPTIONAL: You may upload one file with a maximum of two figures or tables (2 figures, 1 figure and 1 table, or 2 tables). Each figure or table must be numbered and have a clear title.

AFFIRMATIONS

You must select “I agree” to the following affirmations in order to submit the application.

    1. I understand that funding of this scholarship is subject to the approval and availability of grant funds appropriated to NANETS. Therefore, NANETS reserves the right to alter the number of investigator awards, terms and allowances. 
    2. I understand that the submission of a proposal does not guarantee funding.
    3. I certify that, if approved for funding, the proposed study must undergo the review and approval process of applicable oversight/ethics committees (e.g., IRB, EC, IACUC, etc.). 

MENTOR(S) INFORMATION

Add mentors in this section – Name, Email, Institution, Title. Mentors are notified by e-mail of their addition to this submission. If the notification is not received, be sure to check your spam folder. You can not submit until at least one mentor has been added.

SUBMISSION

Once submitted, you CAN NOT edit your research grant proposal. You will receive an email notification that your submission has been completed. If the notification email is not received, be sure to check your spam folder.


Questions

Technical Issues: Please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

Content Questions: Please contact NANETS Staff at This email address is being protected from spambots. You need JavaScript enabled to view it. or (650)762-6387, Monday-Friday 8:00am-5:00pm EST.

Back to Top 

Access the Grant Submissions Portal Here

2025 Abstract Guide HERE

Full 2025 Abstract Booklet HERE

 

2025 Abstracts will be posted individually and searchable by author and abstract number soon. The complete guide of 2025 abstracts presented at the 2025 NANETS Multidisciplinary NET Medical Symposium Abstracts is available above. 



Looking for abstract submission instructions? Click here

Need help searching for NANETS citations in Pancreas and ERC